Natera Inc


Market Cap$13.41B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Natera IncNatera Inc-30.80%-57%14.10.5

Target Price by Analysts

10.8% upsideNatera Target Price DetailsTarget Price

Current Fair Value

13.2% downside

Overvalued by 13.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$13.41 Billion
Enterprise Value$12.90 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-3.78
Outstanding Shares122,802,694
Avg 30 Day Volume1,219,036


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-30.85
Price to Sales14.08
Price to Book Ratio18.77
Enterprise Value to Revenue11.91
Enterprise Value to EBIT-28.9
Enterprise Value to Net Income-30
Total Debt to Enterprise0.03
Debt to Equity0.47

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Natera Inc

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...